查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
BPH 治療市場：按產品類型、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、2023-2030 年預測
市場調查報告書
商品編碼
1290832

BPH 治療市場：按產品類型、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、2023-2030 年預測

Benign Prostatic Hyperplasia Treatment Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 354 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年良性前列腺增生治療市場規模將達到110.54億美元，2023年至2030年復合年增長率為5.9%

良性前列腺增生治療市場 - 市場動態

BPH 治療市場的增長主要是由 BPH 患病率上升推動的。

世界人口迅速承受良性前列腺增生等與年齡相關的疾病的負擔，已成為全球健康的優先事項。BPH 是老年男性常見的泌尿系統疾病。根據屍檢評估，良性前列腺增生的年齡特定患病率在 40 歲時為 8%，在 6 歲時為 50%，在 9 歲時為 80%。主要由於人口增長和老齡化，前列腺增生症的負擔在世界範圍內不斷增加。總體而言，BPH 治療市場的增長主要是由 BPH 患病率上升以及與 BPH 相關的泌尿系統疾病增加推動的。

良性前列腺增生治療市場 - 主要見解

  • 由於可持續增長意識的增強，預計良性前列腺增生治療行業將大幅增長
  • 按產品類型劃分，藥物治療預計將在 2022 年佔據最大的市場份額。
  • 從用途來看，家庭醫療保健是2022年的主要類型。
  • 按地區劃分，北美將在 2022 年銷量領先。

良性前列腺增生治療市場細分分析：

全球良性前列腺增生治療市場根據產品類型、應用、技術和地區進行細分。

根據產品類型，市場分為三類：藥物治療、微創手術、激光治療等。藥物治療在緩解症狀和預防 BPH 進展的市場上佔據主導地位。

市場按應用分為四類：醫院、門診手術中心、專科診所、家庭護理等。家庭醫療保健在市場中佔據主導地位，預計在預測期內將保持其主導地位。此外，患者應在術後數週內繼續服用處方藥。因此，市場更關注家庭護理而不是醫院護理。

良性前列腺增生治療市場 - 地理洞察

從地理上看，該市場遍布北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些地區根據引入業務的國家進一步劃分。由於北美老年人口不斷增長，公眾對可用治療方案的認識不斷提高，預計北美將主導良性前列腺增生治療市場的增長。根據美國社區調查（ACS）數據用戶組的數據，65歲及以上的美國人數量將從2018年的5200萬增加近一倍，到2060年達到9500萬，其中65歲及以上年齡組佔總人口的百分比。預計將從 16% 上升至 23%。良性前列腺增生治療市場受到不同市場驅動因素和不同地區最終用戶行業的影響。良性前列腺增生治療市場的公司正在開發專門的解決方案，以滿足歐洲、亞太地區、拉丁美洲、中東和非洲等地區客戶的特定需求。

良性前列腺增生治療市場 - 競爭格局：

新產品發布、分銷網絡開發、研發支出和併購是公司用來擴大影響力和增加市場份額的一些關鍵技術。每家公司都提供不同的治療方案和技術，治療選擇取決於患者的病情、偏好和醫療保健提供者的專業知識等因素。諮詢泌尿科醫生或醫療保健專業人員非常重要，他們可以評估您的具體情況並推薦最合適的治療方法。例如，Boston Scientific最近宣布從 Celsion 公司購買治療症狀性良性前列腺增生的技術，這一消息是在該公司 6 月 13 日的年會上宣布的。隨後，股東們已經批准了這項收購。

近期動向

2022 年，設計和提供創新醫療技術解決方案的全球技術領導者OLYMPUS宣佈在加拿大首次採用微創 iTind 方法 Did 商業化治療良性前列腺增生 (BPH)。

研究的主要特點

  • 這份關於良性前列腺增生治療市場的研究報告提供了以 2022 年為基準年的市場規模、複合年增長率、估計和預測（2023-2030 年）。
  • 該研究報告為客戶提供了對良性前列腺增生治療市場最新發展的深入了解。
  • 該研究報告闡明了不同細分市場/國家的潛在增長機會，並闡述了良性前列腺增生治療市場有吸引力的投資主張矩陣。
  • 總體報告確定了良性前列腺增生治療市場的新投資機會、現有企業面臨的挑戰以及可持續發展的增長動力
  • 研究範圍內詳細討論了 COVID-19 對 BPH 治療市場規模、預測、複合年增長率和市場動態的影響。它還涵蓋了對新冠疫情後良性前列腺增生治療市場的深入見解。
  • 為了向本報告的用戶提供 BPH 市場的全面了解，還包括 BPH 市場的競爭格局和關鍵創新者分析。
  • 該研究涵蓋了基於市場規模、增長率和吸引力對所有行業領域進行基準測試的增長前景映射分析。
  • 該報告提供了主要市場進入者的詳細公司概況，幫助用戶了解在 BPH 市場運營的公司的財務信息和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要進入者的重大收購和兼併、聯盟和合資企業、新產品推出、研發和區域擴張。
  • 全球良性前列腺增生治療市場報告主要面向該行業的各個利益相關者，如供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第一章良性前列腺增生治療市場概述

  • 調查範圍

第二章執行摘要

  • 市場細分
  • 競爭考慮

第三章 BPH 治療的主要市場趨勢

  • 良性前列腺增生治療市場驅動因素
  • 良性前列腺增生治療市場的製約因素
  • 良性前列腺增生治療市場機會
  • 良性前列腺增生治療市場的未來趨勢

第四章前列腺增生症治療行業概況

  • PEST分析
  • 波特五力分析
  • 繪製增長前景
  • 監管框架分析

第五章 BPH 治療市場：COVID-19 的影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析

第六章良性前列腺增生治療市場格局

  • 2022 年良性前列腺增生治療市場份額分析
  • 主要製造商的細分數據
    • 現有公司分析
    • 啟動分析

7. BPH 治療市場 - 按產品類型

  • 概述
    • 按產品類型劃分的細分市場份額分析
    • 藥物治療
    • 微創手術
    • 激光治療
    • 其他

8.良性前列腺增生治療市場——按應用分類

  • 概述
    • 按應用劃分的細分市場份額分析
    • 醫院
    • 門診手術中心
    • 專科診所
    • 家庭保健
    • 其他

9.良性前列腺增生治療市場——按地區

  • 介紹
  • 北美
    • 概述
    • 北美 BPH 治療的領先製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲良性前列腺增生治療的領先製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區良性前列腺增生治療的領先製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲 BPH 治療的領先製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲前列腺增生症治療的領先製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

10.主要供應商分析-良性前列腺增生治療行業

  • 比賽儀表板
  • 公司簡介
    • Carrier
    • Daikin Industries, Ltd
    • NIBE GroupViessmann Group
    • Glen Dimplex
    • BDR Thermea Group
    • Midea Group
    • Hitachi, Ltd.
    • Ingersoll Rand Plc.
    • STIEBEL ELTRON GmbH &Co. KG
    • Vaillant Group
    • Robert Bosch GmbH
    • The Danfoss Group

第十一章 分析師的全面看法

Product Code: ANV1307

REPORT HIGHLIGHT

Benign Prostatic Hyperplasia Treatment Market size was valued at USD 11,005.4 million in 2022, expanding at a CAGR of 5.9% from 2023 to 2030.

Benign prostatic hyperplasia, a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. Many treatments are available for enlarged prostate. These include medicines, surgery, and procedures that involve smaller, fewer, or no cuts. Furthermore, New BPH treatments are less invasive and damaging to healthy tissue than surgery. In general, most of these treatments are outpatient procedures, which means consumers can go home the same day as the procedure. They're also cheaper, have fewer side effects and allow for a faster recovery.

Benign Prostatic Hyperplasia Treatment Market- Market Dynamics

The growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia.

The global population urging the burden of age-associated diseases, such as benign prostatic hyperplasia, has become a global health priority. Benign prostatic hyperplasia is a common urological disease among older men. The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy evaluations to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. The burden of benign prostatic hyperplasia is rising throughout the world, primarily due to population growth and aging. Overall, the growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia as well as the rise in urological illnesses linked with benign prostatic hyperplasia.

Benign Prostatic Hyperplasia Treatment Market- Key Insights

  • As per the analysis shared by our research analyst, the global Benign Prostatic Hyperplasia Treatment market is estimated to grow annually at a CAGR of around 5.5.% over the forecast period (2023-2030)
  • The Benign Prostatic Hyperplasia Treatment industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Drug treatment was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Home healthcare was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Benign Prostatic Hyperplasia Treatment Market- Segmentation Analysis:

The Global Benign Prostatic Hyperplasia Treatment Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Drug treatment, Minimally Invasive Surgeries, laser therapy, and others. Drug treatment dominates the market due to providing symptom relief and facilitating prevent the progression of BPH.

The market is divided into four categories based on application: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, home healthcare, and Others. Home healthcare dominates the market and is likely to maintain its dominance during the forecast period. Patients should also continue taking their prescriptions for a few weeks after surgery. As a result, in his market, the emphasis is biased toward home healthcare rather than hospital care.

Benign Prostatic Hyperplasia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Benign Prostatic Hyperplasia Treatment market, due to the increasing geriatric population, and rising awareness among the general public about the available treatment options. According to American Community Survey (ACS) Data Users Group, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share of the total population will rise from 16 percent to 23 percent. The Benign Prostatic Hyperplasia Treatment market is influenced by different market drivers and end-user industries across different regions. Companies in the Benign Prostatic Hyperplasia Treatment market develop specialized solutions to meet the specific needs of customers in each region like Europe, Asia pacific, Latin America, the Middle East & Africa, etc.

Benign Prostatic Hyperplasia Treatment Market- Competitive Landscape:

Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. Each of these companies provides different treatment options and technologies, and the choice of treatment depends on factors such as the patient's condition, preferences, and the expertise of the healthcare provider. It's crucial to consult with a urologist or healthcare professional who can assess specific cases and recommend the most appropriate treatment approach. For example, Boston Scientific Corporation recently announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia from Celsion Corporation, following approval of the acquisition by Celsion stockholders at the company's annual meeting on June 13.

Recent Developments:

In 2022, Olympus, a global technology leader in designing and delivering innovative medical technology solutions, announced nowadays the first commercial treatment of Benign Prostatic Hyperplasia (BPH) in Canada using the minimally invasive iTind procedure.

Key features of the study:

  • This proposed research study on Benign Prostatic Hyperplasia Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Benign Prostatic Hyperplasia Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Benign Prostatic Hyperplasia Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Benign Prostatic Hyperplasia Treatment market
  • Impact of COVID-19 on Benign Prostatic Hyperplasia Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Benign Prostatic Hyperplasia Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Benign Prostatic Hyperplasia Treatment market, we have also included competitive landscape and key innovator analysis for the Benign Prostatic Hyperplasia Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Benign Prostatic Hyperplasia Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Benign Prostatic Hyperplasia Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET KEY PLAYERS

  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Endo International plc
  • Urologix, LLC
  • LISA Laser
  • Olympus Corporation
  • Other

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY PRODUCT TYPE

  • Drug Treatment
  • Alpha-blockers
  • 5-Alpha-reductase Inhibitor (5-ARIs)
  • Phosphodiesterase-5 Enzyme Inhibitor
  • Others
  • Minimally Invasive Surgeries
  • Transurethral Resection of the Prostate (TURP)
  • Transurethral Incision of the Prostate (TUIP)
  • Robotic Surgeries
  • Transurethral Microwave Thermotherapy (TUMT)
  • Prostatic Urethral Lift
  • Others
  • Laser Therapy
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY APPLICATION

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home healthcare
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Benign Prostatic Hyperplasia Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Benign Prostatic Hyperplasia Treatment Market Snippet by Product Type
    • 2.1.2. Benign Prostatic Hyperplasia Treatment Market Snippet by Application
    • 2.1.3. Benign Prostatic Hyperplasia Treatment Market Snippet by Country
    • 2.1.4. Benign Prostatic Hyperplasia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Benign Prostatic Hyperplasia Treatment Key Market Trends

  • 3.1. Benign Prostatic Hyperplasia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Benign Prostatic Hyperplasia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Benign Prostatic Hyperplasia Treatment Market Opportunities
  • 3.4. Benign Prostatic Hyperplasia Treatment Market Future Trends

4. Benign Prostatic Hyperplasia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Benign Prostatic Hyperplasia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Benign Prostatic Hyperplasia Treatment Market Landscape

  • 6.1. Benign Prostatic Hyperplasia Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Benign Prostatic Hyperplasia Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Drug Treatment
    • 7.1.3. Minimally Invasive Surgeries
    • 7.1.4. Laser Therapy
    • 7.1.5. Others

8. Benign Prostatic Hyperplasia Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Ambulatory Surgical Centers
    • 8.1.4. Specialty Clinics
    • 8.1.5. Home healthcare
    • 8.1.6. Others

9. Benign Prostatic Hyperplasia Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Benign Prostatic Hyperplasia Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Carrier
    • 10.2.2. Daikin Industries, Ltd
    • 10.2.3. NIBE GroupViessmann Group
    • 10.2.4. Glen Dimplex
    • 10.2.5. BDR Thermea Group
    • 10.2.6. Midea Group
    • 10.2.7. Hitachi, Ltd.
    • 10.2.8. Ingersoll Rand Plc.
    • 10.2.9. STIEBEL ELTRON GmbH & Co. KG
    • 10.2.10. Vaillant Group
    • 10.2.11. Robert Bosch GmbH
    • 10.2.12. The Danfoss Group

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Product Type 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)